vs

Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and TEJON RANCH CO (TRC). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $21.1M, roughly 1.6× TEJON RANCH CO). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 7.5%, a 51.4% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 17.7%). Over the past eight quarters, TEJON RANCH CO's revenue compounded faster (68.8% CAGR vs 39.5%).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Tejon Ranch Company, based in Lebec, California, is one of the largest private landowners in California. The company was incorporated in 1936 to organize the ownership of a large tract of land that was consolidated from four Mexican land grants acquired in the 1850s and 1860s by ranch founder Edward Fitzgerald Beale.

DTIL vs TRC — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.6× larger
DTIL
$34.2M
$21.1M
TRC
Growing faster (revenue YoY)
DTIL
DTIL
+5243.4% gap
DTIL
5261.1%
17.7%
TRC
Higher net margin
DTIL
DTIL
51.4% more per $
DTIL
58.9%
7.5%
TRC
Faster 2-yr revenue CAGR
TRC
TRC
Annualised
TRC
68.8%
39.5%
DTIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DTIL
DTIL
TRC
TRC
Revenue
$34.2M
$21.1M
Net Profit
$20.1M
$1.6M
Gross Margin
30.6%
Operating Margin
36.6%
10.9%
Net Margin
58.9%
7.5%
Revenue YoY
5261.1%
17.7%
Net Profit YoY
213.5%
-64.7%
EPS (diluted)
$2.62
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTIL
DTIL
TRC
TRC
Q4 25
$34.2M
$21.1M
Q3 25
$13.0K
$12.0M
Q2 25
$18.0K
$8.3M
Q1 25
$29.0K
$8.2M
Q4 24
$638.0K
$17.9M
Q3 24
$576.0K
$10.9M
Q2 24
$49.9M
$5.7M
Q1 24
$17.6M
$7.4M
Net Profit
DTIL
DTIL
TRC
TRC
Q4 25
$20.1M
$1.6M
Q3 25
$-21.8M
$1.7M
Q2 25
$-23.5M
$-1.7M
Q1 25
$-20.6M
$-1.5M
Q4 24
$4.5M
Q3 24
$-16.4M
$-1.8M
Q2 24
$32.7M
$957.0K
Q1 24
$8.6M
$-914.0K
Gross Margin
DTIL
DTIL
TRC
TRC
Q4 25
30.6%
Q3 25
28.4%
Q2 25
40.9%
Q1 25
15.0%
Q4 24
42.9%
Q3 24
22.9%
Q2 24
45.3%
Q1 24
0.3%
Operating Margin
DTIL
DTIL
TRC
TRC
Q4 25
36.6%
10.9%
Q3 25
-158976.9%
-16.9%
Q2 25
-121538.9%
-48.8%
Q1 25
-76248.3%
-50.7%
Q4 24
11.9%
Q3 24
-3693.6%
-34.9%
Q2 24
48.4%
-62.4%
Q1 24
-23.8%
-53.8%
Net Margin
DTIL
DTIL
TRC
TRC
Q4 25
58.9%
7.5%
Q3 25
-167476.9%
14.0%
Q2 25
-130666.7%
-20.6%
Q1 25
-70913.8%
-17.8%
Q4 24
25.0%
Q3 24
-2851.6%
-16.9%
Q2 24
65.6%
16.8%
Q1 24
48.8%
-12.3%
EPS (diluted)
DTIL
DTIL
TRC
TRC
Q4 25
$2.62
$0.05
Q3 25
$-1.84
$0.06
Q2 25
$-2.13
$-0.06
Q1 25
$-2.21
$-0.05
Q4 24
$0.16
Q3 24
$-2.25
$-0.07
Q2 24
$4.67
$0.04
Q1 24
$1.70
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTIL
DTIL
TRC
TRC
Cash + ST InvestmentsLiquidity on hand
$115.6M
$9.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$92.2M
$475.2M
Total Assets
$154.4M
$630.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTIL
DTIL
TRC
TRC
Q4 25
$115.6M
$9.5M
Q3 25
$44.9M
$3.6M
Q2 25
$62.2M
$2.5M
Q1 25
$77.2M
$12.3M
Q4 24
$86.3M
$39.3M
Q3 24
$101.2M
$27.4M
Q2 24
$123.6M
$33.0M
Q1 24
$137.8M
$35.6M
Stockholders' Equity
DTIL
DTIL
TRC
TRC
Q4 25
$92.2M
$475.2M
Q3 25
$16.6M
$473.2M
Q2 25
$34.1M
$471.5M
Q1 25
$49.3M
$472.5M
Q4 24
$56.4M
$473.6M
Q3 24
$64.9M
$468.3M
Q2 24
$74.7M
$469.2M
Q1 24
$37.2M
$467.4M
Total Assets
DTIL
DTIL
TRC
TRC
Q4 25
$154.4M
$630.5M
Q3 25
$93.5M
$629.6M
Q2 25
$108.9M
$618.5M
Q1 25
$124.4M
$614.6M
Q4 24
$136.4M
$608.0M
Q3 24
$153.3M
$598.0M
Q2 24
$165.8M
$590.8M
Q1 24
$184.7M
$581.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTIL
DTIL
TRC
TRC
Operating Cash FlowLast quarter
$-11.3M
$6.1M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
3.88×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTIL
DTIL
TRC
TRC
Q4 25
$-11.3M
$6.1M
Q3 25
$-15.3M
$-2.4M
Q2 25
$-20.3M
$-381.0K
Q1 25
$-19.1M
$-1.3M
Q4 24
$-58.4M
$14.3M
Q3 24
$-5.9M
$2.1M
Q2 24
$-14.9M
$-1.8M
Q1 24
$-19.0M
$777.0K
Free Cash Flow
DTIL
DTIL
TRC
TRC
Q4 25
$-11.3M
Q3 25
$-14.6M
Q2 25
$-20.3M
$-20.0M
Q1 25
$-19.1M
$-18.9M
Q4 24
$-58.7M
$-42.9M
Q3 24
$-6.0M
$-16.8M
Q2 24
$-14.9M
$-15.8M
Q1 24
$-19.1M
$-7.3M
FCF Margin
DTIL
DTIL
TRC
TRC
Q4 25
-32.9%
Q3 25
-122.2%
Q2 25
-112627.8%
-240.6%
Q1 25
-65917.2%
-230.1%
Q4 24
-9199.8%
-239.3%
Q3 24
-1033.2%
-155.2%
Q2 24
-29.9%
-277.2%
Q1 24
-108.4%
-99.0%
Capex Intensity
DTIL
DTIL
TRC
TRC
Q4 25
0.1%
Q3 25
0.0%
102.3%
Q2 25
11.1%
236.0%
Q1 25
220.7%
213.7%
Q4 24
39.2%
319.1%
Q3 24
6.8%
174.3%
Q2 24
0.1%
245.5%
Q1 24
0.5%
109.5%
Cash Conversion
DTIL
DTIL
TRC
TRC
Q4 25
-0.56×
3.88×
Q3 25
-1.43×
Q2 25
Q1 25
Q4 24
3.19×
Q3 24
Q2 24
-0.45×
-1.88×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons